Agreed. Kiss and make up and pay whoever loses some sort of a golden handshake incentive. Source some projects, move on.On the plus side, my 0.002 order may get filled... but yeah, hopefully acquisitions are still going ahead amidst all this.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling